Page 1 of Clinical Trials for AUR, 18 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker
Last Updated: May 19, 2008
Condition(s): Urinary Retention; Benign Prostatic Hyperplasia
2
Terminated
Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
Last Updated: June 15, 2011
Condition(s): Prostatic Hyperplasia; Urinary Retention; Acute Disease
3
Terminated
Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
Last Updated: June 15, 2011
Condition(s): Prostatic Hyperplasia; Urinary Retention
4
Active, not recruiting
Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database
Last Updated: June 23, 2011
Condition(s): Prostatic Hyperplasia
5
Completed
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
Last Updated: March 15, 2012
Condition(s): Benign Prostatic Hyperplasia; Prostatic Hyperplasia
6
Terminated
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
Last Updated: November 26, 2007
Condition(s): Benign Prostatic Hyperplasia
7
Completed
Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database
Last Updated: June 16, 2011
Condition(s): Prostatic Hyperplasia
8
Completed
Clinical Trial in Males With BPH (Enlarged Prostate)
Last Updated: June 6, 2008
Condition(s): Urinary Retention; Prostatic Hyperplasia; Benign Prostatic Hypertrophy
9
Completed
Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
Last Updated: September 15, 2011
Condition(s): Benign Prostatic Hyperplasia
10
Completed
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH
Last Updated: March 10, 2009
Condition(s): Prostatic Hyperplasia; Acute Urinary Retention
11
Completed
Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia
Last Updated: February 16, 2012
Condition(s): Prostatic Hyperplasia
12
Completed
Alfuzosin for Treating Acute Urinary Retention
Last Updated: September 14, 2009
Condition(s): Acute Urinary Retention
13
Completed
Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia
Last Updated: December 8, 2011
Condition(s): Prostatic Hyperplasia
14
Completed
Efficacy and Safety Study of Dutasteride and Tamsulosin Followed by Counseling on Flexible Dosing of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia (BPH)
Last Updated: August 2, 2011
Condition(s): Benign Prostatic Hyperplasia
15
Completed
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Last Updated: April 19, 2012
Condition(s): Neoplasms, Prostate; Prostate Cancer
16
Recruiting
Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
Last Updated: July 29, 2011
Condition(s): Lower Urinary Tract Symptoms
17
Completed
Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)
Last Updated: September 12, 2005
Condition(s): Staphylococcus Aureus Bacteremia
18
Completed
Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs
Last Updated: September 6, 2006
Condition(s): Staphylococcus Aureus

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=AUR

Page 1 of Clinical Trials for AUR, 18 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About